Gadd45β deficiency in rheumatoid arthritis: Enhanced synovitis through JNK signaling

Arthritis and Rheumatism

Volumn 60, Issue 11, 2009, Pages 3229-3240

  Svensson, Camilla I ^a,d   Inoue, Tomoyuki ^a   Hammaker, Deepa ^a   Fukushima, Akihisa ^a   Papa, Salvatore ^b   Franzoso, Guido ^b   Schett, Georg ^c   Corr, Maripat ^a   Boyle, David L ^a   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; GADD45B PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAP2K7 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOARTHRITIS; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM; ANIMAL; ARTHRITIS; CELL CULTURE; DISEASE MODEL; GENETICS; HOSPITALIZATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, DIFFERENTIATION; ARTHRITIS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MAP KINASE KINASE 4; MAP KINASE KINASE 7; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MICE; MICE, KNOCKOUT; NF-KAPPA B; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SYNOVITIS;

EID: 70350537163     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24887     Document Type: Article

References (37)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-361
2. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001;108:73-81. (Pubitemid 32634924)
3. Han Z, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 1998;28:197-208. (Pubitemid 29027651)
4. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene 1991;6:165-167 (Pubitemid 21923998)
5. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. The NF-κB-mediated control of ROS and JNK signaling. Histol Histopathol 2006;21:69-80. (Pubitemid 43033716)
6. Jin R, De Smaele E, Zazzeroni F, Nguyen DU, Papa S, Jones J, et al. Regulation of the gadd45β promoter by NF-κB. DNA Cell Biol 2002;21:491-503.
7. Papa S, Monti SM, Vitale RM, Bubici C, Jayawardena S, Alvarez K, et al. Insights into the structural basis of the GADD45β- mediated inactivation of the JNK kinase, MKK7/JNKK2. J Biol Chem 2007;282:19029-19041 (Pubitemid 47100151)
8. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S, et al. Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 2004;6: 146-153 (Pubitemid 38425714)
9. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, et al. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 2001;414:308-313 (Pubitemid 33097807)
10. Sundarrajan M, Boyle DL, Chabaud-Riou M, Hammaker D, Firestein GS. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum 2003;48:2450-2460 (Pubitemid 37129422)
11. Inoue T, Hammaker D, Boyle DL, Firestein GS. Regulation of JNK by MKK-7 in fibroblast-like synoviocytes. Arthritis Rheum 2006;54:2127-2135 (Pubitemid 44051068)
12. Liu L, Tran E, Zhao Y, Huang Y, Flavell R, Lu B. Gadd45β and Gadd45γ are critical for regulating autoimmunity. J Exp Med 2005;202:1341-1347 (Pubitemid 41668737)
13. Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M, et al. Down-regulation of growth arrest DNA damage-inducible gene 45β expression is associated with human hepatocellular carcinoma. Am J Pathol 2003;162:1961-1974 (Pubitemid 36613053)
14. Qiu W, Zhou B, Chu PG, Luh F, Yen Y. The induction of growth arrest DNA damage-inducible gene 45β in human hepatoma cell lines by S-adenosylmethionine. Am J Pathol 2007;171:287-296 (Pubitemid 47339245)
15. Papa S, Zazzeroni F, Fu YX, Bubici C, Alvarez K, Dean K, et al. Gadd45β promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling. J Clin Invest 2008;118: 1911-1923 (Pubitemid 351632393)
16. Larsen CM, Dossing MG, Papa S, Franzoso G, Billestrup N, Mandrup-Poulsen T. Growth arrest- and DNA-damage-inducible 45β gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1β-induced apoptosis in insulin-producing INS-1E cells. Diabetologia 2006;49:980-989
17. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1790-1798
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
19. Rosengren S, Boyle DL, Firestein GS. Acquisition, culture, and phenotyping of synovial fibroblasts. Methods Mol Med 2007;135: 365-375
20. Kyburz D, Corr M. The KRN mouse model of inflammatory arthritis. Springer Semin Immunopathol 2003;25:79-90. (Pubitemid 37000040)
21. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, et al. The K/BxN mouse model of inflammatory arthritis: theory and practice. Methods Mol Med 2007;136:269-282
22. Zwerina J, Tuerk B, Redlich K, Smolen JS, Schett G. Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis. Arthritis Res Ther 2006;8:R22.
23. Svensson CI, Fitzsimmons B, Azizi S, Powell HC, Hua XY, Yaksh TL. Spinal p38β isoform mediates tissue injury-induced hyperalgesia and spinal sensitization. J Neurochem 2005;92:1508-1520 (Pubitemid 40389219)
24. Boyle DL, Rosengren S, Bugbee W, Kavanaugh A, Firestein GS. Quantitative biomarker analysis of synovial gene expression by real-time PCR. Arthritis Res Ther 2003;5:R352-60.
25. Aupperle K, Bennett B, Han Z, Boyle D, Manning A, Firestein G. NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J Immunol 2001;166:2705-2711 (Pubitemid 32173511)
26. Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994;8: 2996-3007.
27. Yamamoto A, Miyazaki T, Kadono Y, Takayanagi H, Miura T, Nishina H, et al. Possible involvement of IκB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor κB ligand. J Bone Miner Res 2002;17:612-621 (Pubitemid 34246636)
28. Hirayama T, Dai S, Abbas S, Yamanaka Y, Abu-Amer Y. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-κB activation. Arthritis Rheum 2005;52:2719-2729 (Pubitemid 41369100)
29. Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991;34:1094-1105
30. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006;11:529-543
31. Han Z, Boyle DL, Aupperle KR, Bennett B, Manning AM, Firestein GS. Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther 1999;291:124-130 (Pubitemid 29451581)
32. Dharmapatni AA, Smith MD, Findlay DM, Holding CA, Evdokiou A, Ahern MJ, et al. Elevated expression of caspase-3 inhibitors, survivin and XIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther 2009;11: R13.
33. Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002;3:360-365 (Pubitemid 34308624)
34. Du F, Wang L, Zhang Y, Jiang W, Sheng H, Cao Q, et al. Role of GADD45β in the regulation of synovial fluid T cell apoptosis in rheumatoid arthritis. Clin Immunol 2008;128:238-247
35. Ijiri K, Zerbini LF, Peng H, Otu HH, Tsuchimochi K, Otero M, et al. Differential expression of GADD45β in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum 2008;58:2075-2087 (Pubitemid 351988099)
36. Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, et al. A novel role for GADD45β as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 2005;280:38544-38555 (Pubitemid 43853754)
37. Yoshizawa T, Hammaker D, Sweeney SE, Boyle DL, Firestein GS. Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases. J Immunol 2008;181:3252-3258